Acute cardiac care & resuscitation

Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: 1-Year Outcomes of the Multicentre, Randomized ECMO-CS Trial

Eur J Heart FailPublished Secondary analysis of the ECMO-CS randomised trial

Primary result · All-cause deathResult — go to the resultHazard ratio 1.02 95% CI 0.66–1.58

Authors' conclusion

Among patients with severe or rapidly progressing cardiogenic shock, immediate initiation of ECMO did not improve clinical outcomes at 1 year compared to the early conservative strategy.

Study context

Population
Patients with severe or rapidly progressing cardiogenic shock
Participants
117 patients
Comparison
Immediate extracorporeal membrane oxygenation (ECMO) vs early conservative strategy
  • ECMOn = 58
  • Early conservativen = 59reference
Primary endpoint
All-cause mortality
Follow-up
1 year
Methodological detailsmulticentre, 1-year follow-up
  • Multicentre
  • 1-year follow-up

Primary result

All-cause death

Hazard ratio

1.02

95% CI 0.66–1.58

P = 0.93

Events by treatment group

ECMOvs Early conservative
HR 1.02 (95% CI 0.66–1.58); P = 0.93

As reported in the abstract

Secondary outcomes

OutcomeECMOEarly conservativeHR (95% CI)P value
Composite of death, resuscitated cardiac arrest or another mechanical circulatory support device · 1 year74.1%79.7%0.83 (0.55–1.25)P = 0.29

Duration of mechanical ventilation, intensive care unit (ICU) stay and hospital stay

Comparable between groups

1-year mortality by baseline mean arterial pressure (MAP) (unplanned post-hoc subgroup analysis)

Lower mortality with treatment strategy in low baseline MAP (<63 mmHg) subgroup
HR 0.58, 95% CI 0.29-1.16
  • Pinteraction = 0.017
  • Unplanned post-hoc subgroup analysis

Original publication

Extracorporeal Membrane Oxygenation in the Therapy of Cardiogenic Shock: 1-Year Outcomes of the Multicentre, Randomized ECMO-CS Trial. Eur J Heart Fail. Published 8 August 2024. doi:10.1002/ejhf.3398

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.